[HTML][HTML] Poor mobilization of hematopoietic stem cells—definitions, incidence, risk factors, and impact on outcome of autologous transplantation
P Wuchter, D Ran, T Bruckner, T Schmitt… - Biology of Blood and …, 2010 - Elsevier
As more efficient agents for stem cell mobilization are being developed, there is an urgent
need to define which patient population might benefit from these novel drugs. For a precise …
need to define which patient population might benefit from these novel drugs. For a precise …
[HTML][HTML] Poor Mobilization of Hematopoietic Stem Cells–Definitions, Incidence, Risk Factors and Impact On Outcome of Autologous Transplantation.
P Wuchter, D Ran, T Schmitt, T Bruckner… - Blood, 2009 - Elsevier
Abstract Abstract 2153 Poster Board II-130 Hematopoietic progenitor and stem cells (HSC)
reside in the bone marrow and have to be mobilized into the circulation prior to being …
reside in the bone marrow and have to be mobilized into the circulation prior to being …
[HTML][HTML] Poor Mobilization of Hematopoietic Stem Cells—Definitions, Incidence, Risk Factors, and Impact on Outcome of Autologous Transplantation
P Wuchter, D Ran, T Bruckner, T Schmitt… - Biology of Blood and …, 2010 - astctjournal.org
As more efficient agents for stem cell mobilization are being developed, there is an urgent
need to define which patient population might benefit from these novel drugs. For a precise …
need to define which patient population might benefit from these novel drugs. For a precise …
[PDF][PDF] Poor Mobilization of Hematopoietic Stem Cells—Definitions, Incidence, Risk Factors, and Impact on Outcome of Autologous Transplantation
P Wuchter, D Ran, T Bruckner, T Schmitt… - Biol Blood Marrow …, 2010 - scholar.archive.org
Peripheral blood stem cells (PBSCs) have largely replaced bone marrow (BM) cells in
autologous transplantations, and have become the source of stem cells in the majority of …
autologous transplantations, and have become the source of stem cells in the majority of …
Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation
P Wuchter, D Ran, T Bruckner… - Biology of blood …, 2010 - pubmed.ncbi.nlm.nih.gov
As more efficient agents for stem cell mobilization are being developed, there is an urgent
need to define which patient population might benefit from these novel drugs. For a precise …
need to define which patient population might benefit from these novel drugs. For a precise …
[PDF][PDF] Poor Mobilization of Hematopoietic Stem Cells—Definitions, Incidence, Risk Factors, and Impact on Outcome of Autologous Transplantation
P Wuchter, D Ran, T Bruckner, T Schmitt… - Biol Blood Marrow …, 2010 - cyberleninka.org
Peripheral blood stem cells (PBSCs) have largely replaced bone marrow (BM) cells in
autologous transplantations, and have become the source of stem cells in the majority of …
autologous transplantations, and have become the source of stem cells in the majority of …
Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation.
P Wuchter, D Ran, T Bruckner, T Schmitt… - Biology of Blood and …, 2009 - europepmc.org
As more efficient agents for stem cell mobilization are being developed, there is an urgent
need to define which patient population might benefit from these novel drugs. For a precise …
need to define which patient population might benefit from these novel drugs. For a precise …
Poor Mobilization of Hematopoietic Stem Cells–Definitions, Incidence, Risk Factors and Impact On Outcome of Autologous Transplantation.
P Wuchter, D Ran, T Schmitt, T Bruckner… - 2009 - ashpublications.org
Abstract Abstract 2153 Poster Board II-130 Hematopoietic progenitor and stem cells (HSC)
reside in the bone marrow and have to be mobilized into the circulation prior to being …
reside in the bone marrow and have to be mobilized into the circulation prior to being …
Poor Mobilization of Hematopoietic Stem Cells—Definitions, Incidence, Risk Factors, and Impact on Outcome of Autologous Transplantation
P Wuchter, D Ran, T Bruckner, T Schmitt… - Biology of Blood and …, 2010 - infona.pl
As more efficient agents for stem cell mobilization are being developed, there is an urgent
need to define which patient population might benefit from these novel drugs. For a precise …
need to define which patient population might benefit from these novel drugs. For a precise …
[HTML][HTML] Poor Mobilization of Hematopoietic Stem Cells—Definitions, Incidence, Risk Factors, and Impact on Outcome of Autologous Transplantation
P Wuchter, D Ran, T Bruckner, T Schmitt… - Biology of Blood and …, 2010 - tctjournal.org
As more efficient agents for stem cell mobilization are being developed, there is an urgent
need to define which patient population might benefit from these novel drugs. For a precise …
need to define which patient population might benefit from these novel drugs. For a precise …